There is no associated downtime and the individual can continue their daily activities after receiving the therapy
Potential Benefits & Side Effects What topical, in-vitro and animal literature describe
A 2025 meta-analysis of randomized trials found small-to-moderate improvements in attention and task switching
doi:10.1016/j.jad.2011.06.005 Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani MR, Hosseini SM, Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi SM, Moghadam M, Gharibi F, Mirshafiee O, Akhondzadeh S (2013) N -acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study